Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises

References

• American Psychiatric Association. 2013. Obsessive-compulsive and related disorders. diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing. p 235–264.
   Google Scholar
• Bae JS, Han HS, Youn DH, Carter JE, Modo M, Schuchman H, et al. 2007. Bone marrow derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells 25:1307–1316.
   PubMed Web of Science ®Google Scholar
• Baier PC, May U, Scheller J, Rose-john S, Schiffelholz T. 2009. Impaired hippocampus-dependent and -independent learning in IL-6 deficient mice. Behav Brain Res 200: 192–196.
   PubMed Web of Science ®Google Scholar
• Bang OY, Lee JS, Lee PH, Lee G. 2005. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57: 874–882.
   PubMed Web of Science ®Google Scholar
• Boer K, Crino PB, Gorter JA, Nellist M, Jansen FE, Spliet WGM, et al. 2010. Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol 20:704–719.
   PubMed Web of Science ®Google Scholar
• Cao Q, Benton RL, Whittemore SR. 2002. Stem cell repair of central nervous system injury. J Neurosci Res 68:501–510.
   PubMed Web of Science ®Google Scholar
• Careaga M, Schwartzer J, Ashwood P. 2015. Inflammatory profiles in the BTBR mouse: how relevant are they to autism spectrum disorders? Brain Behav Immun 43:11–16.
   PubMedGoogle Scholar
• Derecki NC, Cronk JC, Kipnis J. 2013. The role of microglia in brain maintenance: implications for Rett syndrome. Trends Immunol 34:144–150.
   PubMed Web of Science ®Google Scholar
• Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, et al. 2010. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 59: 1662–1669.
   PubMed Web of Science ®Google Scholar
• García-Gómez I, Elvira G, Zapata AG, Lamana ML, Ramirez M, Garcia Castro J, et al. 2010. Mesenchymal stem cells: biological properties and clinical applications. Expert Opin Biol Ther 10:1453–468.
   PubMed Web of Science ®Google Scholar
• Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noël D. 2010. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 1:2.
   PubMed Web of Science ®Google Scholar
• Giunti D, Parodi B, Usai C, Vergani L, Casazza S, Bruzzone S, et al. 2012. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells 30: 2044–2053.
   PubMed Web of Science ®Google Scholar
• Harden LM, Du plessis I, Poole S, Laburn HP. 2008. Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats. Brain Behav Immun 22:838–849.
   PubMed Web of Science ®Google Scholar
• Javazon EH, Beggs KJ, Flake AW. 2004. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32:414–425.
   PubMed Web of Science ®Google Scholar
• Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. 2010. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 5:933–946.
   PubMed Web of Science ®Google Scholar
• Karp JM, Leng Teo GS. 2009. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4:206–216.
   PubMed Web of Science ®Google Scholar
• Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, et al. 2008. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65:753–761.
   PubMed Web of Science ®Google Scholar
• Klingemann H, Matzilevich D, Marchand J. 2008. Mesenchymal stem cells – sources and clinical applications. Transfus Med Hemother 35:272–277.
   PubMed Web of Science ®Google Scholar
• Lavelle TA, Weinstein MC, Newhouse JP, Munir K, Kuhlthau KA, Prosser LA. 2014. Economic burden of childhood autism spectrum disorders. Pediatrics 133:520–529.
   PubMed Web of Science ®Google Scholar
• Lepperdinger G, Brunauer R, Jamnig A, Laschober G, Kassem M. 2008. Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies?. Exp Gerontol 43: 1018–1023.
   PubMed Web of Science ®Google Scholar
• Li X, Chauhan A, Sheikh AM, Sheikh AM, Patil S, Chauhan V, et al. 2009. Elevated immune response in the brain of autistic patients. J Neuroimmunol 207:111–116.
   PubMed Web of Science ®Google Scholar
• Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. 2015. Structural and functional features of central nervous system lymphatic vessels. Nature 523:337–341 doi:10.1038/nature14432.
   PubMed Web of Science ®Google Scholar
• Lv YT, Zhang Y, Liu M, Qiuwaxi J, Ashwood P, Cho S, et al. 2013. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med 11:196.
   PubMed Web of Science ®Google Scholar
• Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ. 2015. Cytokine aberrations in austism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry 20: 440–446.
   PubMed Web of Science ®Google Scholar
• MMWR CDC. 2014. Prevalence of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR CDC 63:1–21.
   PubMed Web of Science ®Google Scholar
• Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. 2005. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 102:18171–18176.
   PubMed Web of Science ®Google Scholar
• Onore C, Careaga M, Ashwood P. 2012. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26:383–392.
   PubMed Web of Science ®Google Scholar
• Pardo CA, Vargas DL, Zimmerman AW. 2005. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 17:485–495.
   PubMed Web of Science ®Google Scholar
• Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. 2011. Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456–1458.
   PubMed Web of Science ®Google Scholar
• Petrie Aronin CE, Tuan RS. 2010. Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res C Embryo Today 90:67–74.
   PubMed Web of Science ®Google Scholar
• Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, et al. 2006. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390–1397.
   PubMed Web of Science ®Google Scholar
• Saresella M, Marventano I, Guerini FR, Mancuso R, Ceresa L, Zanzottera M, et al. 2009. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry 66:978–984.
   PubMed Web of Science ®Google Scholar
• Sharma A, Badhe P, Gokulchandran, Kulkarni P, Mishra P, Shetty A, et al. 2013a. An improved case of autism as revealed by PET CT scan in patient transplanted with autologous bone marrow derived mononuclear Cells. J Stem Cell Res Ther 3:2.
   Google Scholar
• Sharma A, Gokulchandran N, Sane H, et al. 2013b. Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study. Stem Cells Int 2013:623875.
   PubMed Web of Science ®Google Scholar
• Siniscalco D, Giordano C, Galderisi U, Luongo L, Alessio N, Di Bernardo G et al. 2010. Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol Life Sci 67:655–669.
   PubMed Web of Science ®Google Scholar
• Siniscalco D, Sapone A, Cirillo A, Giordano C, Maione S, Antonucci N. 2012. Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future? J Biomed Biotechnol 2012:480289.
   PubMed Web of Science ®Google Scholar
• Siniscalco D, Bradstreet JJ, Sych N, Antonucci N. 2013. Perspectives on the use of stem cells for autism treatment. Stem Cells In 2013:262438.
   Google Scholar
• Siniscalco D, Bradstreet JJ, Sych N, Antonucci N. 2014. Mesenchymal stem cells in treating autism: Novel insights. World J Stem Cells 6:173–178.
   PubMedGoogle Scholar
• Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, et al. 2009. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27:1421–1432.
   PubMed Web of Science ®Google Scholar
• Tetreault NA, Hakeem AY, Jiang S, Williams BA, Allman E, Wold BJ, et al. 2012. Microglia in the cerebral cortex in autism. J Autism Dev Disord 42:2569–2584.
   PubMed Web of Science ®Google Scholar
• Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67–81.
   PubMed Web of Science ®Google Scholar
• Willenborg DO. 2003. Neuroinflammation: mechanisms and management, 2nd ed. Immunol Cell Biol 81:237–238.
   Google Scholar
• Wu J, Sun Z, Sun HS, Wu J, Weisel RD, Keating A, et al. 2008. Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant 16:993–1005.
   PubMed Web of Science ®Google Scholar
• Yuskaitis CJ, Beurel E, Jope RS. 2010. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochim Biophys Acta 1802:1006–1012.
   PubMed Web of Science ®Google Scholar
• Zahn Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, Pagani F, et al. 2014. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nature Neurosci 17:400–406.
   PubMed Web of Science ®Google Scholar
• Zalcman SS. 2002. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Res 944:157–164.
   PubMed Web of Science ®Google Scholar